Found 9 matching trials
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma PHASE2 This phase II trial tests the safety and effectiveness of glofitamab given ...
Show More Location
University of California, Davis
Learn More & Join Trial
The clonoSEQ® Watch Registry N/A This is a prospective, multicenter, observational study of adult patients w...
Show More Location
Stanford Hospital
Learn More & Join Trial
MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma PHASE2 This is a phase II pilot, single arm, open label study designed to assess t...
Show More Location
Multiple Locations
Learn More & Join Trial
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy N/A In this study, invesigators propose to analyze 150 DLBCL patients, 50 MCL p...
Show More Location
Stanford Cancer Center
Learn More & Join Trial
A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP PHASE2 Older patients with diffuse large B- cell lymphoma (DLBCL) do not have the ...
Show More Location
Wilmot Cancer Institute
Learn More & Join Trial
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD PHASE1 A pilot study to assess the risk of progression after stopping post-autolog...
Show More Location
University of Illinois Cancer Center
Learn More & Join Trial
Non-invasive MRD Assessment in Multiple Myeloma N/A The purpose of this study is to investigate the sensitivity and accuracy of...
Show More Location
New York Presbyterian Hospital/Columbia University Irving Medical Center
Learn More & Join Trial
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance PHASE2 This study evaluates an individualized approach combining highly active mai...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas N/A The purpose of this study is to determine whether a blood test can accurate...
Show More Status
Active Not Recruiting
Location
University of Miami
Learn More & Join Trial